EXENATIDE Drug Patent Profile
Which patents cover Exenatide, and when can generic versions of Exenatide launch?
Exenatide is a drug marketed by Amneal and is included in one NDA.
The generic ingredient in EXENATIDE is exenatide synthetic. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the exenatide synthetic profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for EXENATIDE?
- What are the global sales for EXENATIDE?
- What is Average Wholesale Price for EXENATIDE?
Summary for EXENATIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for EXENATIDE |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for EXENATIDE |
| DailyMed Link: | EXENATIDE at DailyMed |
Recent Clinical Trials for EXENATIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The First Affiliated Hospital of Henan University of Science and Technology | EARLY_PHASE1 |
| PegBio Co., Ltd. | EARLY_PHASE1 |
| National University of Singapore | PHASE2 |
Anatomical Therapeutic Chemical (ATC) Classes for EXENATIDE
US Patents and Regulatory Information for EXENATIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal | EXENATIDE SYNTHETIC | exenatide synthetic | INJECTABLE;SUBCUTANEOUS | 206697-001 | Nov 19, 2024 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Amneal | EXENATIDE SYNTHETIC | exenatide synthetic | INJECTABLE;SUBCUTANEOUS | 206697-002 | Nov 19, 2024 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
